Down Syndrome Screening

Down syndrome or Down's syndrome is an incurable genetic disorder that is mainly diagnosed after birth. However, mothers can also undergo antenatal screening to help predict how likely it is that their baby will be born with the condition.

Several standard non-invasive pre-natal tests for Down's syndrome are recommended and these are often combined in order to increase the accuracy of testing. However, none are definitive tests and only amniocentesis, chorionic villus sampling (CVS) or percutaneous umbilical cord blood sampling (PUBS) can confirm a diagnosis.

According to guidelines form the American Congress of Obstetricians and Gynecologists, both non-invasive tests such as ultrasonography and invasive tests such as amniocentesis, CVS and PUBS should be offered to all women, regardless of their age. However, the invasive tests are usually only offered if the maternal age is over 34 years at the time of conception or if the non-invasive tests reveal a risk of Down's syndrome. This is because both amniocentesis and CVS carry a small risk (0.5 to 1%) of causing fetal damage, bleeding or miscarriage.

For women who would like to be screened during pregnancy, these tests are usually taken in the late part of the first trimester or early part of the second trimester.

The non-invasive screening procedures for Down's syndrome that are available to pregnant women are listed in the box below.

Test Time of Testing Description
Combined test 10 to 14 weeks of pregnancy Ultrasonography is used to measure nuchal translucency and the mother's blood is tested for free beta human chorionic gonadotropin (hCG) and PAPP-A (pregnancy-associated plasma protein A)
Quad screen 15 to 20 weeks of pregnancy For this test, four parameters are measured in the mother:
Alpha fetoprotein (a fetal liver protein)
Estriol
hCG
Inhibin-alpha
Integrated test 15 to 20 weeks of pregnancy This combines the quad screen with PAPP-A and nuchal translucency.

Screening pregnancies for the presence of Down's syndrome helps parents in more than one way. Firstly, if the results are normal, parents can enjoy the rest of the pregnancy feeling reassured that their baby will be born healthy. Secondly, if the results confirm a diagnosis of Down's syndrome, parents can begin to prepare for looking after a baby that will have additional needs. Some parents who receive a positive diagnosis may also consider the possibility of a termination.

Further Reading

Last Updated: Jun 17, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 17). Down Syndrome Screening. News-Medical. Retrieved on October 14, 2024 from https://www.news-medical.net/health/Down-Syndrome-Screening.aspx.

  • MLA

    Mandal, Ananya. "Down Syndrome Screening". News-Medical. 14 October 2024. <https://www.news-medical.net/health/Down-Syndrome-Screening.aspx>.

  • Chicago

    Mandal, Ananya. "Down Syndrome Screening". News-Medical. https://www.news-medical.net/health/Down-Syndrome-Screening.aspx. (accessed October 14, 2024).

  • Harvard

    Mandal, Ananya. 2023. Down Syndrome Screening. News-Medical, viewed 14 October 2024, https://www.news-medical.net/health/Down-Syndrome-Screening.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
APOE4 gene linked to early onset Alzheimer's, target for therapeutic intervention